Bladmir-S 50 Tablet ER
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Mirabegron (50mg) + Solifenacin (5mg)
Overview Bladmir-S 50 Tablet ER
Combining two active ingredients, Bladmir-S 50 ER tablets effectively manage overactive bladder symptoms. This medication provides relief from frequent urination, urgency, and incontinence. Always adhere to your physician's prescribed dosage and duration; it can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Common side effects include elevated blood pressure, upper respiratory tract inflammation, urinary tract infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Prior to commencing treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment require close monitoring and regular check-ups under medical supervision.
Uses of Bladmir-S 50 Tablet ER
Symptoms associated with an overactive bladder
Major Benefits of Bladmir-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Bladmir-S 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this extended-release tablet can be taken with or without food, consistent timing is recommended.
Common Side effects of Bladmir-S 50 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Bladmir-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Bladmir-S 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This extended-release medication can be taken with or without food, though consistent timing is recommended.
How Bladmir-S 50 Tablet ER works:
Bladmir-S 50 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves similar bladder muscle relaxation through a different mechanism. This combined action reduces the frequency, urgency, and incontinence associated with overactive bladder.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Bladmir-S 50 Tablet ER requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Bladmir-S 50 Tablet ER use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Bladmir-S 50 Tablet ER for breastfeeding mothers is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Bladmir-S 50 Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Bladmir-S 50 Tablet ER use in individuals with impaired renal function is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Bladmir-S 50 Tablet ER in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Bladmir-S 50 Tablet ER :
NA
Facts to Know About Bladmir-S 50 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | The study of the urinary tract. |
3,018 People bought this recently